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Abstract: The metabolic syndrome (MetS) is a constellation of cardiometabolic risk factors that
identifies people at increased risk for type 2 diabetes and cardiovascular disease. While the global
prevalence is 20%–25% of the adult population, the prevalence varies across different racial/ethnic
populations. In this narrative review, evidence is reviewed regarding the assessment, management
and prevention of MetS among people of different racial/ethnic groups. The most popular definition
of MetS considers race/ethnicity for assessing waist circumference given differences in visceral adipose
tissue and cardiometabolic risk. However, defining race/ethnicity may pose challenges in the clinical
setting. Despite 80% of the world’s population being of non-European descent, the majority of
research on management and prevention has focused on European-derived populations. In these
studies, lifestyle management has proven an effective therapy for reversal of MetS, and randomised
studies are underway in specific racial/ethnic groups. Given the large number of people at risk
for MetS, prevention efforts need to focus at community and population levels. Community-based
interventions have begun to show promise, and efforts to improve lifestyle behaviours through
alterations in the built environment may be another avenue. However, careful consideration needs to
be given to take into account the unique cultural context of the target race/ethnic group.
Keywords: metabolic syndrome; ethnicity; prevention; lifestyle; cardiometabolic
1. Introduction
The metabolic syndrome (MetS) is a constellation of cardiometabolic risk factors that results in an
increased risk for type 2 diabetes (T2D), cardiovascular disease and premature mortality [1]. At its
foundation is insulin resistance, in which the actions of insulin decrease, resulting in hyperinsulinemia.
Left unchecked, insulin resistance can progress to MetS and prediabetes, and further to T2D. MetS is
defined as the presence of at least three of the following five common clinical measures, which occur in
people with insulin resistance: elevated triglycerides (TG), low high-density lipoprotein cholesterol
(HDL-C), elevated blood sugar, elevated blood pressure (BP) and elevated waist circumference (WC)
(Table 1, Table 2) [2].Within primary care and other front-line care environments, the MetS is a simple
tool with which to identify people with insulin resistance and prediabetes, and therefore, at early
risk for T2D and cardiovascular disease. As a result, it provides an opportune time for primary care
providers to intervene and prevent progression to overt disease.
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Table 1. Criteria of the metabolic syndrome defined as three of more of the five measures.
Measure Threshold
Elevated triglycerides ≥1.70 mmol/L *
Reduced HDL-C ≤1.00 mmol/L (males) *≤1.30 mmol/L (females) *
Elevated blood pressure Systolic ≥ 130 mmHg and/orDiastolic ≥ 85 mmHg *
Elevated fasting glucose ≥5.6 mmol/L *
Elevated waist circumference See population-specific thresholds in Table 2
* Or appropriate drug treatment. HDL-C = high-density lipoprotein cholesterol.
Table 2. Population-specific waist circumference thresholds [2].
Population Men Women
Central/South American, Chinese, Japanese, South Asian ≥90 cm ≥80 cm
Mediterranean, Middle East, Sub-Saharan African ≥94 cm ≥80 cm
Europid (includes Canada, Europe and United States) * ≥102 cm(≥94 cm)
≥88 cm
(≥88 cm)
* While thresholds of ≥94 cm for men and ≥80 cm for women are more common in research, the thresholds of ≥102
for men and ≥88 for women are used more commonly in clinical practice.
Despite the ease of assessment, the worldwide prevalence of MetS is not known [3,4], in part due
to MetS not being a common clinical indicator, such as T2D, and thus not widely assessed. Further
complicating estimates is the variation in definitions used in countries before, and even since [5], the
MetS definition was harmonised in 2009 [2]. However, estimates suggest the worldwide prevalence
of MetS to be 20%–25% of the population, based on a presumed prevalence threefold higher than
T2D [4]. As the prevalence of obesity and T2D is expected to rise, so too is the prevalence of MetS.
In countries where prevalence data do exist, it is clear that it differs by country. For example, the
estimated prevalence of MetS in the United States is 33.4% [6], while in China, it is 14.4% [7].
The difference in MetS prevalence across countries is likely the result of different governmental,
institutional and sociocultural factors at the population level, which can affect a range of upstream
determinants including, but not limited to, the type of available foods and access, health care policies,
education, employment and the physical environment. This is in addition to individual factors such as
biology/genetics and sociocultural aspects, which are also likely relevant to the different prevalence
of MetS between countries. These latter aspects may be collectively referred to as ethnic or racial
differences, as many of these characteristics often cluster in specific and identifiable populations.
Even within the same country, in the same local environment, the prevalence of MetS differs along
certain predefined racial/ethnic groups. For example, in the United States, the prevalence of MetS
is highest in Hispanics and lowest in African-Americans, with the prevalence of MetS in whites in
between the two [8]. (It is important to recognise that the term “white” does not describe an ethnicity
or ethnic group. The use of the term “white” in this article is only used when the authors of the original
article that has been cited have used this term to describe one of their study populations without
providing additional information on that group’s ethnic origins.) While recent national level data in
Canada have not been reported, an earlier study reported MetS to be highest in people of Indigenous
ancestry, followed by South Asians, Europeans and East Asians [9]. In Singapore, MetS is highest in
South Asians, followed by Malays and then people of Chinese background [10]. Understanding the
influence race/ethnicity has with respect to MetS is important for its proper assessment, treatment
and prevention.
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Ethnicity and race are fluid constructs that have no clear-cut definition, which are often (and
incorrectly) used interchangeably. Despite these challenges, ethnicity and race are still used in medical
literature as a means to differentiate between populations and recognise such differences in health
management and disease prevention. Furthernore, ethnic and racial groupings often differ across
the medical literature based on the research purpose, methods of data collection and even the lens
of the researchers themselves. While individuals may ascribe their ethnicity within sociocultural
aspects, medical guidelines such as those for the MetS attempt to define ethnicity primarily on common
biomedical (whether biological or genetic) and/or geographical aspects. These are generally broad
classifications, which often group multiple ethnic and racial groups into one. Sometimes this is based
exclusively on geographical origins (for example, “Asian” or “European”) without recognising the
ethnic or racial heterogeneity within these groupings and thus incorrectly inferring that the populations
are homogeneous. While some biomedical characteristics align with certain ethnic and racial groups,
this should not be interpreted that ethnicity and race are biomedical constructs, nor should ethnic and
racial classifications be interpreted to reflect genetic variation.
It should also be noted that ethnicity and race are not the same. Race infers some biological
foundations for differences among groups, while ethnicity views populations from a more social/cultural
lens. However, these terms may be used in medical literature as if they are the same. Across the
many papers cited in this review, some authors grouped study participants into categories they termed
“race”, while others used groupings termed “ethnicity”, commonly without defining the terms or the
categories. This lack of consistency makes it challenging to compare and contrast across the various
studies. As a result, for the sake of this review, the terms are combined (albeit not ideally) into one
called “race/ethnicity”, and when citing research, we have used the same race/ethnicity group names
as the original authors.
2. Assessment
Of the five cardiometabolic risk factors, four of the definition thresholds apply to all race/ethnic
groups. The fifth, WC, entails different threshold values based on race/ethnic background (Table 2).
These differing thresholds are based on evidence that the association between WC, an indicator of
abdominal obesity, and risk of cardiometabolic diseases differs by race/ethnicity. For example, at a
similar WC, people of Chinese and South Asian background have higher values of total cholesterol
and other cardiometabolic risk factors compared with people of European background [11–13]. If the
goal is to identify people at the same level of cardiometabolic risk, lower WC thresholds for people of
Asian background were created.
The requirement for lower WC thresholds in some racial/ethnic groups has its foundation in the
differences in visceral adipose tissue (VAT). In particular, people of Asian backgrounds (South Asian,
East Asian, Southeast Asian) have higher amounts of VAT at a given body size and WC [14]. For South
Asians, this higher amount of VAT accounts for much of their elevated cardiometabolic risk compared
with European-derived populations [15]. In African-Americans, VAT tends to be lower than whites at
a similar body size [16]. Despite a higher prevalence of obesity and T2D [17,18], levels of VAT in North
American Indigenous populations appear to be similar to that of Europeans of the same size [14,19].
While the use of race/ethnic-specific WC thresholds is reflective of the differing risk in different
racial/ethnic groups, it can pose a challenge during assessment of MetS. This is reflected in the above
biological foundations for having different WC thresholds for MetS. It must be acknowledged that
the MetS uses a broad definition of race/ethnicity and population grouping based on geographical
location, which does not reflect the many varying races and ethnicities within those groupings. There is
even limited agreement in how race/ethnicity is defined [20]; however, it is probably best defined by
self-report, meaning, each individual is likely to provide the most “accurate” identification of their
own race/ethnicity.
In predominantly homogeneous populations found in many parts of Asia, the use of
race/ethnic-specific WC thresholds should not pose a challenge [21]. However, in diverse populations
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such as in Europe and the Americas, determining the race/ethnicity of a patient can be challenging [22].
While self-identification may be the best indicator of race/ethnicity, this may be a conversation in which
health care professionals may feel uncomfortable engaging. In addition, people who descend from a
different geographical or race/ethnic region from where they currently live may identify more with the
local context than their ancestral one. This may result in a conflict between how an individual identifies
his/herself and how race/ethnicity is defined in the health system. In many locations, people may also
identify with more than one race/ethnicity. Guessing on the part of the health care professional may
be no better. The increasingly common prevalence of offspring from mixed ethnic partnerships can
further complicate the matter [23], as there are no studies on how to apply the race/ethnic-specific WC
thresholds to these individuals.
3. Treatment
As MetS allows for the presence of overt risk factors such as hypercholesterolemia, hypertension
and T2D, when present, these should be treated as per local clinical guidelines. For patients with MetS
but without overt risk factors, treatment through lifestyle therapy is effective at reversing MetS. In the
Diabetes Prevention Program (55% white, 20% African-American, 16% Hispanic, 5% Native American
and 4% Asian in the original trial [24], no analysis by race/ethnicity), the combined intervention
of physical activity and diet resulted in a more than twofold reversal of the MetS compared with
the placebo group and a 65% greater reversal rate than the metformin group [25]. A subsequent
meta-analysis of combined physical activity and diet interventions found a twofold greater rate of
MetS reversal compared with control interventions [26].
In isolation, regular aerobic physical activity of low-to-moderate intensity has resulted in reversal
of the MetS in postmenopausal women (65% white, 30% African-American and 6% other in original
trial [27], no analysis by race/ethnicity) [28] and reduction in MetS severity in a workplace setting
using a wrist-worn activity monitor and smartphone app designed to enhance physical activity
(conducted in Germany, race/ethnicity not reported) [29]. In addition to aerobic exercise interventions,
a 12-week resistance training program was effective in reversing MetS in older women (race/ethnicity
not reported) [30]. However, aerobic physical activity alone in men and women (56% white, 44%
African-American) or a combination of aerobic and resistance physical activity may be superior to
resistance training alone [31]. A randomised trial in Norwegian men and women focused on differing
intensities of exercise on reversing the MetS is currently underway [32].
A secondary analysis in the PREDIMED randomised trial of participants with the MetS
(approximately 97% European) at the study’s onset reported the Mediterranean diet resulted in
an approximately 28%–35% reversal of MetS compared with the control diet [33]. However, due to
later concerns with the PREDIMED methods [34] and republication with a smaller sample attesting
to similar conclusions [35], the exact effect of the intervention may not be accurately reflected in
this analysis.
Despite more than 80% of the world’s population being of non-European descent, the
overwhelming majority of research on MetS is limited by the predominant focus on European-derived
populations and a lack of race/ethnic-specific analyses. In terms of the benefits of interventions aimed
at reducing or reversing MetS in other race/ethnic groups, few studies exist. Short-term diet studies
have reported reversal of MetS in Iranians [36], South Asians [37] and people of Asian descent living in
the United States [38]. A combined lifestyle intervention in Arabs living in Saudi Arabia reported a
greater reduction in MetS compared with the group receiving general advice [39]. One randomised
trial currently underway is investigating a combined lifestyle intervention of physical activity, nutrition
improvement and weight loss in a diverse population in the United Kingdom [40], while another
exercise-focused trial in African-American women with MetS is also in progress [41].
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3.1. Comprehensive Lifestyle Interventions
Much information on reversing MetS may also be gleaned from randomised intervention studies
that target individual components of the MetS or prevention/treatment of T2D. A small randomised
study of Japanese men with MetS reported that a three-month intervention of diet and physical activity
reduced WC and glycated haemoglobin, along with a nonsignificant reduction in MetS prevalence
compared to control [42]. In African-Americans with T2D, a lifestyle weight loss intervention of 12
weeks resulted in lower weight, improved BP and glycaemic control compared with usual care after six
months [43]. Similarly, a six-month weight loss program in African-Americans in the Southern United
States resulted in reduction of WC and BP [44]. The Da Qing Diabetes Prevention Study in China
reported reduced incidence of T2D by 45% following six years of a diet and physical activity intervention
in people with glucose intolerance [45]. In Hispanic obese women, a community implementation
of the Diabetes Prevention Program resulted in a greater decrease in WC and improved glycaemic
control compared with metformin or standard care after 12 months [46]. In Brazil, a randomised
intervention of lifestyle counselling resulted in improvements in WC and BP [47]. A nonrandomised
study of translation of the Diabetes Prevention Program in Aboriginal people in the United States
showed promise in reducing risk for T2D [48]. In Jewish and Bedouin women with post-gestational
diabetes, a lifestyle counselling intervention resulted in reduction in glucose [49]. In South Asians
living in the United Kingdom, compared with control, a diet and physical activity intervention resulted
in improved WC but not glucose and BP after two years [50].
3.2. Nutritional Interventions
A wide variety of nutritional interventions ranging from macronutrient comparisons to
supplementation with single foods or supplements have been carried out in a number of racial/ethnic
groups. The most common dietary interventions are those focused on energy restriction in order to
target weight loss, which generally improves cardiometabolic risk factors [51–53]. More recent attention
has focused on the macronutrient combinations, and in particular, low-carbohydrate diets. A number
of small randomised studies have indicated low-carbohydrate diets to result in more favourable
improvements to glucose, insulin sensitivity, triglycerides and HDL-C [54], which may be independent
of weight loss, suggesting a specific mechanism by which carbohydrates may promote cardiometabolic
risk [55]. However, not all studies are in agreement and a meta-analysis of 23 randomised trials
reported no difference in cardiometabolic risk factors between low-carbohydrate and low-fat diets [56].
In non-European-derived populations, diets with an emphasis on fruits and vegetables, healthy
proteins and sodium reduction (such as the DASH diet) have demonstrated reductions in BP among
African-Americans [57,58], East Asians [59,60] and South Asians [61,62]. For people with T2D,
dietary interventions consisting of nutrition counselling following local guidelines for T2D care
have resulted in improved glycaemic control, lipids and anthropometric measures in Arabs [63] and
African-Americans [64]. Overweight and obese Malaysian adults undergoing a six-month trial of
a high-protein, high-fibre diet had improvements to WC and glucose metabolism compared with
control [65]. Studies in South Asians focusing on healthy protein, whether through meal replacement
or nut supplementation, have reported reductions in glucose and WC, along with increases in
HDL-C [61,62,66]. In Chinese men and women, a number of different randomised dietary interventions
(high-protein, low-carbohydrate diets) have resulted in reductions in WC and lipid measures [67,68].
Diet supplemented with whole grain oats over six months reduced WC in Chinese men and women
compared with control [69]. Very few studies have investigated interventions in Indigenous populations.
A randomised study of flaxseed supplementation in Native Americans resulted in lowering low-density
lipoprotein cholesterol (LDL-C) but did not affect HDL-C or TG [70], while a high-protein diet in Maori
in New Zealand resulted in a greater decrease in WC compared with a low-fat or control diet [71].
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3.3. Physical Activity Interventions
Numerous studies of various forms of physical activity have been conducted in a range of
populations. In randomised trials, exercise interventions have demonstrated improvements in one or
more of the components of MetS in South Asians [72–74] and East Asians [75,76]. In Chinese men, an
intervention of Tai Chi was effective at reducing BP and TG [77]. Less is known about how similar
interventions may be effective in African-American, Hispanic and Aboriginal/Indigenous populations.
However, higher levels of physical activity and fitness have been reported to be associated with a
lower prevalence of MetS in African-Americans [78], Hispanics [79] and Aboriginals [80].
To complement physical activity interventions, consideration should be given to interventions
to limit sedentary behaviour such as sitting. Prospective studies have reported extended sedentary
time to be positively associated with increased risk for type 2 diabetes, cardiovascular disease and
premature mortality [81]. These associations occur even independently of physical activity levels.
Cross-sectional studies in Americans [82], Brazilians [83] and Koreans [84] have reported positive
associations between sedentary time and MetS. Randomised interventions aimed at reducing sedentary
time have proven successful in increasing physical activity [85,86].
4. Prevention
Given the overall numbers of people with, and at risk for, MetS in most countries, individual-based
prevention approaches are unlikely to be efficient and feasible. Instead, prevention strategies should be
targeted to populations at the community level [87] and must be culturally tailored, as what works in
one race/ethnic group may not necessarily work in another. These can vary from upstream, high-level
policy initiatives to downstream, on the ground programs targeted at high-risk groups.
Policies such as the introduction of a sugar tax show promise. A high consumption of sugar, and
sugar-sweetened beverages in particular, has been associated with a higher prevalence of MetS in a
number of countries [88,89]. Countries and regions that have implemented a sugar tax have reported
reductions in the consumption of sugar-sweetened beverages [90–92]. However, at present, there is no
evidence to indicate this translates into a reduction in the incidence of MetS or its components, most
likely because these policies are relatively new and may need more time for a downstream effect to
be realised.
Another area influenced by policy at the local level is the built environment, which comprises the
human-made infrastructure in which we live. This consists of such things as the street network, the
placement of stores, community centres and residential areas, as well as the presence of sidewalks.
Aspects of the built environment are associated with both physical activity and diet [93] and may be an
upstream determinant for MetS.
People living in areas that are considered walkable (such as those with high street connectivity,
mixed land use, and sidewalks) have higher physical activity levels and are at lower risk for T2D
compared with those living in nonwalkable areas [94]. Similarly, living in an area with a high proportion
of fast food restaurants and limited opportunities to buy healthy foods is associated with a greater
prevalence of obesity [95]. These findings are consistent with a systematic review, which found
cross-sectional associations of the built environment with obesity, hypertension and MetS, such that
areas considered more walkable had a lower prevalence of these conditions [96]. Being cross-sectional,
these studies cannot provide insight into causal relations or address the possible numerous confounders
such as socioeconomic status (SES) and that some people are able to choose their neighbourhood based
on their preferred lifestyle, while others may be limited in opportunities of residential movement as a
result of their SES and race/ethnic minority status due to historical segregation. A limited number
of longitudinal studies have reported that changes in the built environment associated with more
walkability have corresponded with increased walking [97,98].
While some studies have indicated that the local food environment is associated with diets of nearby
residents [99,100], not all studies have [101]. Similarly, the association of the food environment with
risk factors is less clear. Some studies reported a positive association between fast food restaurants and
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obesity [95,102], a negative association between supermarkets and obesity [103], while others observed
no association between food stores and obesity [104]. However, it appears these associations may
depend on socioeconomic strata, which in heterogeneous populations often aligns along race/ethnicity,
as the positive relationship between fast food restaurants and obesity was strongest in those with
the lowest income [100,105]. Whether interventions to change the local food environment affect risk
for the MetS is not known. Introduction of a supermarket in an area previously absent of any had
a modest effect on diet quality, such as reduced sugar consumption in nearby residents compared
with a control neighbourhood [106]. However, dietary assessment was conducted less than a year
after the supermarket opened, and it may take a longer time, and more supermarkets, to change food
purchasing behaviours.
Of importance is that many people in high- and middle-income countries who are at high
risk for MetS are also among those with the lowest SES [107,108]. In addition, in countries with a
diverse population, racial/ethnic minorities tend to be the most marginalised in that society. In lower
SES communities, there are fewer opportunities for physical activity (such as green areas and
community centres), less access to grocery stores and supermarkets (which sell healthy foods) and
a higher proportion of fast food restaurants [109,110]. Targeted built environment interventions in
these high-risk communities may be worthwhile to improve lifestyle behaviours known to protect
against MetS.
While built environment initiatives affect the whole population, targeting interventions in high-risk
communities by bringing prevention strategies to places where people gather have demonstrated
substantial promise. These types of programs are needed, as access to health services for prevention
and treatment (whether physical or cultural) is often worse for those of lower SES and/or of a minority
racial/ethnic status [111]. In African-American communities in the United States, this has taken on the
form of BP interventions at local barbershops. Both encouragement of lifestyle modification by their
barber and integration with onsite pharmacists resulted in significant BP reductions, with the latter
intervention being significantly better than barber encouragement alone [112]. Similar intervention
studies are ongoing in faith-based communities and places of worship [113].
Success has also been reported using workplace interventions, which have resulted in
improvements in activity and nutrition compared with control [114]. In Delhi, a multifactorial
six-month worksite intervention focusing on education resulted in improvements in HDL-C, TG and
WC compared with control groups [115]. Others have looked at translating successful interventions
in European-derived populations to different racial/ethnic groups and delivering them in local
communities. These studies have demonstrated significant reduction in MetS risk factors in
African-Americans, [116] Hispanics [117,118] and South Asians living in India, Pakistan and the
United Kingdom [119–121]. Community initiatives have also worked in increasing physical activity
through walking programs in Hispanic neighbourhoods [122] and improving nutrition through local
dietary counselling in African-American neighbourhoods [123]. Other community-based interventions
have reported improvements in HDL-C, BP and WC compared with control in Taiwan [124].
A cluster-randomised study of communes in Vietnam found a six-month physical activity and nutrition
intervention also improved cardiometabolic risk factors and a slightly better reduction in prevalence
of MetS compared with an educational intervention [125]. In Iran, community-based educational
programs have been successful in reducing the incidence of MetS compared with nonintervention
controls [126,127].
Another area of promise for individual interventions but on a population scale is the use of
consumer technology devices such as tablets, smartphones and wearables. A number of randomised
studies have reported on experimental interventions that have improved lifestyle behaviours and/or
cardiometabolic risk factors related to MetS, whether through wearable technology, smartphone apps
or simple text messaging [29,128,129]. With the increasing ubiquity of global ownership of these
devices, the opportunity to leverage these technologies to intervene on a population level has grown.
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Recent studies have demonstrated the possible effectiveness of large-scale interventions [130] and the
feasibility of reach in pragmatic trials [131].
5. Other Considerations
While both physical activity and dietary interventions are likely to be efficacious treatments for
MetS, the intervention that is effective in one racial/ethnic group may not be effective in a different
racial/ethnic group. This can be due to not only different cultural contexts of physical activity and diet
but also due to structural barriers and policies, which cater to the majority population and may pose
barriers to maintaining health and disease prevention for minority populations. Various cultures also
view physical activity in different lights. For example, South Asians have lower physical activity levels
compared with other populations [132,133], which may be rooted in cultural context [134]. In addition,
adherence to and enjoyment of exercise may be based on the physical activity type, which also may
have cultural relevance, such as Bhangra dance in South Asians [73] or Tai Chi in East Asians [135].
Similarly, food is strongly rooted in culture, and availability and cost may differ from place to
place. Therefore, interventions need to consider what foods target groups have access to, the cultural
meaning of food and the financial opportunity of the individuals. If interventions are not designed
taking cultural preferences into account, they are unlikely to be engaged by the population and be
successful [136]. In addition to cultural differences, in many high-income countries, many racial/ethnic
groups comprise a minority population and are commonly marginalised in society, creating further
barriers for treatment. To be effective, interventions must also address real and perceived structural
barriers and policies present within each racial/ethnic group. For example, as a result of residential
schools in Canada, there is distrust between people of Aboriginal background and government-funded
health care [137]. Therefore, trust in the health care system and health care professionals, who may not
be from the same community, is needed before effective prevention and intervention can begin [138].
6. Future Directions and Conclusions
Despite more than 80% of the world’s population being of non-European descent, the
overwhelming majority of research on MetS, from prevalence to treatment, is in predominantly
European-derived populations. This is a critical gap in knowledge given that cardiometabolic risk
may differ along racial/ethnic lines. Indeed, the recognised different WC thresholds reflect the
nuances of race/ethnicity when assessing MetS. Current evidence in prevention and treatment of MetS
suggests lifestyle interventions proved in European-derived populations can be effective at treating
and reversing MetS; however, they need to be translated into the local cultural context to ensure success.
For widespread prevention of MetS, interventions targeted at the population level are likely to be most
successful. In order to grow our knowledge of MetS in different populations around the world, we
need to conduct more rigorous cohort and randomised trials in populations beyond those of European
descent. In addition, studies in countries with significant diversity should include unrepresented
racial/ethnic groups as well as analyses stratified by race/ethnicity.
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